Citations (99)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Muhammad Shahbaz, Sairah Hafeez Kamran & Rukhsana Anwar. (2021) Amelioration of Bleomycin and Methotrexate-Induced Pulmonary Toxicity by Serratiopeptidase and Fisetin. Nutrition and Cancer 73:11-12, pages 2774-2784.
Read now
Read now
Zhen-hua Zhu, Xing Li, Lin-feng He, He-fei Cai, Bin Ye & Zhong-min Wu. (2021) Glycyrrhizic acid, as an inhibitor of HMGB1, alleviates bleomycin-induced pulmonary toxicity in mice through the MAPK and Smad3 pathways. Immunopharmacology and Immunotoxicology 43:4, pages 461-470.
Read now
Read now
Shilpa Johnson, Sadiya B. Shaikh, Fatheema Muneesa, Barki Rashmi & Yashodhar P. Bhandary. (2020) Radiation induced apoptosis and pulmonary fibrosis: curcumin an effective intervention?. International Journal of Radiation Biology 96:6, pages 709-717.
Read now
Read now
Maja D. Andersen, Peter Kamper, Alexander d’Amore, Michael Clausen, Hans Bentzen & Francesco d'Amore. (2019) The incidence of bleomycin induced lung toxicity is increased in Hodgkin lymphoma patients over 45 years exposed to granulocyte-colony stimulating growth factor. Leukemia & Lymphoma 60:4, pages 927-933.
Read now
Read now
James D. Williamson, Laura R. Sadofsky, Michael G. Crooks, John Greenman & Simon P. Hart. (2016) Bleomycin increases neutrophil adhesion to human vascular endothelial cells independently of upregulation of ICAM-1 and E-selectin. Experimental Lung Research 42:8-10, pages 397-407.
Read now
Read now
Articles from other publishers (94)
Asmaa Mohamed Abdel-Aziz, Eman Mahmoud Fathy, Heba M. Hafez, Amira F. Ahmed & Mervat Z. Mohamed. (2023) TLR4/ MyD88/NF-κB signaling pathway involved in the protective effect of diacerein against lung fibrosis in rats. Human & Experimental Toxicology 42.
Crossref
Crossref
Dan Wang, Bochuan Deng, Lu Cheng, Jieru Li, Xiaomin Guo, Jiao Zhang, Xiang Zhang, Ping Su, Guofeng Li, Xiaokang Miao, Wenle Yang, Junqiu Xie & Rui Wang. (2023)
The novel peptide
DR4penA
attenuates the bleomycin‐ and paraquat‐induced pulmonary fibrosis by suppressing the
TGF
‐
β
/Smad signaling pathway
. The FASEB Journal 37:11.
Crossref
Crossref
Lanlan Liu, Xiaoli Zhang, Ruihong Zhang, Liyan Wang, Sujuan Zhi, Xiaoning Feng, Xuyue Liu, Ying Shen & Jing Hao. (2023) Sohlh2 promotes pulmonary fibrosis via repression of p62/Keap1/Nrf2 mediated anti-oxidative signaling pathway. Cell Death & Disease 14:10.
Crossref
Crossref
Ting Huang, Ruyi Lin, Yuanqin Su, Hao Sun, Xixi Zheng, Jinsong Zhang, Xiaoyan Lu, Baiqin Zhao, Xinchi Jiang, Lingling Huang, Ni Li, Jing Shi, Xiaohui Fan, Donghang Xu, Tianyuan Zhang & Jianqing Gao. (2023) Efficient intervention for pulmonary fibrosis via mitochondrial transfer promoted by mitochondrial biogenesis. Nature Communications 14:1.
Crossref
Crossref
Eun-Ah Sung, Min Hee Park, Octavian Henegariu, Patricia J. Sime & Wook-Jin Chae. (2023) Dickkopf1 Promotes Pulmonary Fibrosis upon Bleomycin-Induced Lung Injury. The American Journal of Pathology 193:9, pages 1130-1142.
Crossref
Crossref
Bakthavatchalam Loganathan Ayilya, Akshad Balde, Murugadoss Ramya, Soottawat Benjakul, Se-Kwon Kim & Rasool Abdul Nazeer. (2023) Insights on the mechanism of bleomycin to induce lung injury and associated in vivo models: A review. International Immunopharmacology 121, pages 110493.
Crossref
Crossref
Lin Li, Rong‐jie Jin & Lu Ji. (2023) Pachymic acid ameliorates bleomycin‐induced pulmonary fibrosis through inhibiting endoplasmic reticulum stress in rats. Environmental Toxicology.
Crossref
Crossref
Giovanni Ligresti, Ahmed A. Raslan, Jeongmin Hong, Nunzia Caporarello, Marco Confalonieri & Steven K. Huang. (2023) Mesenchymal cells in the Lung: Evolving concepts and their role in fibrosis. Gene 859, pages 147142.
Crossref
Crossref
Mutlu Seyran, Scalise Melanie, Stumbles Philip, Gazdhar Amiq & Blank Fabian. (2022) Allies or enemies? The effect of regulatory T cells and related T lymphocytes on the profibrotic environment in bleomycin-injured lung mouse models. Clinical and Experimental Medicine 23:4, pages 1075-1088.
Crossref
Crossref
Wen-Chi Wei, Chia-Ching Liaw, Keng-Chang Tsai, Chun-Tang Chiou, Yu-Hwei Tseng, Wen-Fei Chiou, Yu-Chi Lin, Chia-I Tsai, Chen-Shien Lin, Chen-Sung Lin, Kuo-Tong Liou, I-Shing Yu, Yuh-Chiang Shen & Yi-Chang Su. (2022) Targeting spike protein-induced TLR/NET axis by COVID-19 therapeutic NRICM102 ameliorates pulmonary embolism and fibrosis. Pharmacological Research 184, pages 106424.
Crossref
Crossref
Shuchan Li, Jianrong Shi & Huifang Tang. (2021) Animal models of drug-induced pulmonary fibrosis: an overview of molecular mechanisms and characteristics. Cell Biology and Toxicology 38:5, pages 699-723.
Crossref
Crossref
Martin Kolb, Stylianos E. Orfanos, Chris Lambers, Kevin Flaherty, Alison Masters, Lisa Lancaster, Adam Silverstein & Steven D. Nathan. (2022) The Antifibrotic Effects of Inhaled Treprostinil: An Emerging Option for ILD. Advances in Therapy 39:9, pages 3881-3895.
Crossref
Crossref
Zachary T. Rosenkrans, Christopher F. Massey, Ksenija Bernau, Carolina A. Ferreira, Justin J. Jeffery, Jefree J. Schulte, Melissa Moore, Frank Valla, Jeanine M. Batterton, Christopher R. Drake, Alan B. McMillan, Nathan Sandbo, Ali Pirasteh & Reinier Hernandez. (2022) [68 Ga]Ga-FAPI-46 PET for non-invasive detection of pulmonary fibrosis disease activity. European Journal of Nuclear Medicine and Molecular Imaging 49:11, pages 3705-3716.
Crossref
Crossref
Alexis Perreault, Kelly Harper, Mégane LebelMartine Charbonneau, Damien Adam, Emmanuelle Brochiero, André M. CantinMartin Leduc, Lyne Gagnon & Claire M. Dubois. (2022)
Human Lung Tissue Implanted on the Chick Chorioallantoic Membrane as a Novel
In Vivo
Model of Idiopathic Pulmonary Fibrosis
. American Journal of Respiratory Cell and Molecular Biology 67:2, pages 164-172.
Crossref
Crossref
Jutaro Fukumoto, Muling Lin, Mudassir Meraj Banday, Sahebgowda Sidramagowda Patil, Sudarshan Krishnamurthy, Mason Breitzig, Ramani Soundararajan, Lakshmi Galam, Venkata Ramireddy Narala, Colleen Johns, Kapilkumar Patel, John Dunning, Richard F. Lockey, Nirmal S. Sharma & Narasaiah Kolliputi. (2022) Aberrant Expression of ACO1 in Vasculatures Parallels Progression of Idiopathic Pulmonary Fibrosis. Frontiers in Pharmacology 13.
Crossref
Crossref
Cory Wilson, Tinne C.J. Mertens, Pooja Shivshankar, Weizen Bi, Scott D. Collum, Nancy Wareing, Junsuk Ko, Tingting Weng, Ram P. Naikawadi, Paul J. Wolters, Pascal Maire, Soma S.K. Jyothula, Rajarajan A. Thandavarayan, Dewei Ren, Nathan D. Elrod, Eric J. Wagner, Howard J. Huang, Burton F. Dickey, Heide L. Ford & Harry Karmouty-Quintana. (2022) Sine oculis homeobox homolog 1 plays a critical role in pulmonary fibrosis. JCI Insight 7:10.
Crossref
Crossref
Danielle Galdino de Souza, Débora Silva Santos, Karina Smidt Simon, José Athayde Vasconcelos Morais, Luísa Coutinho Coelho, Thyago José Arruda Pacheco, Ricardo Bentes Azevedo, Anamélia Lorenzetti Bocca, César Augusto Melo-Silva & João Paulo Figueiró Longo. (2022) Fish Oil Nanoemulsion Supplementation Attenuates Bleomycin-Induced Pulmonary Fibrosis BALB/c Mice. Nanomaterials 12:10, pages 1683.
Crossref
Crossref
Yeqing Chen, linling Li, wenlong Wang, Yunpeng Sun, zilin Dong, Yingman Li & Xinsheng Fan. (2022) Serum metabolomic research of the anti-pulmonary fibrosis effects of Shuangshen Pingfei Formula on bleomycin-induced pulmonary fibrosis rats. Journal of Chromatography B 1197, pages 123225.
Crossref
Crossref
Adolf Koudelka, Veronika Cechova, Mauricio Rojas, Nilay Mitash, Anna Bondonese, Claudette St. Croix, Mark A. Ross & Bruce A. Freeman. (2022) Fatty acid nitroalkene reversal of established lung fibrosis. Redox Biology 50, pages 102226.
Crossref
Crossref
Mona H. Zohny, Simona Cavalu, Mahmoud E. Youssef, Mohamed M.Y. Kaddah, Ahmed A.E. Mourad, Ahmed Gaafar Ahmed Gaafar, Eman El-Ahwany, Noha A. Amin, Heba M. Arakeep, Ahmed Shata, Safaa Saleh, Mohamed M. Hafez, Sara T. Elazab, Rasha Abdelhady, Rehab Mohamed El Shahat, Galal Yahya & Sameh Saber. (2022) Coomassie brilliant blue G-250 dye attenuates bleomycin-induced lung fibrosis by regulating the NF-κB and NLRP3 crosstalk: A novel approach for filling an unmet medical need. Biomedicine & Pharmacotherapy 148, pages 112723.
Crossref
Crossref
Biwei Pei, Na Zhang, Tingting Pang & Gengyun Sun. (2022) Linagliptin ameliorates pulmonary fibrosis in systemic sclerosis mouse model via inhibition of endothelial-to-mesenchymal transition. Molecular and Cellular Biochemistry 477:4, pages 995-1007.
Crossref
Crossref
Badr Alzahrani, Mohamed M. S. Gaballa, Ahmed A. Tantawy, Maha A. Moussa, Salma A. Shoulah & Said M. Elshafae. (2022) Blocking Toll-like receptor 9 attenuates bleomycin-induced pulmonary injury. Journal of Pathology and Translational Medicine 56:2, pages 81-91.
Crossref
Crossref
Laura Kalfeist, Loïck Galland, Fanny Ledys, François Ghiringhelli, Emeric Limagne & Sylvain Ladoire. (2022) Impact of Glucocorticoid Use in Oncology in the Immunotherapy Era. Cells 11:5, pages 770.
Crossref
Crossref
Eike B. Preuß, Stephanie Schubert, Christopher Werlein, Helge Stark, Peter Braubach, Anne Höfer, Edith K.J. Plucinski, Harshit R. Shah, Robert Geffers, Katherina Sewald, Armin Braun, Danny D. Jonigk & Mark P. Kühnel. (2022) The Challenge of Long-Term Cultivation of Human Precision-Cut Lung Slices. The American Journal of Pathology 192:2, pages 239-253.
Crossref
Crossref
Roxana Maria Wasnick, Irina Shalashova, Jochen Wilhelm, Ali Khadim, Nicolai Schmidt, Holger Hackstein, Andreas Hecker, Konrad Hoetzenecker, Werner Seeger, Saverio Bellusci, Elie El Agha, Clemens Ruppert & Andreas Guenther. (2022) Differential LysoTracker Uptake Defines Two Populations of Distal Epithelial Cells in Idiopathic Pulmonary Fibrosis. Cells 11:2, pages 235.
Crossref
Crossref
Hagir B. Suliman, Zachary Healy, Fabio Zobi, Bryan D. Kraft, Karen Welty-Wolf, Joshua Smith, Christina Barkauskas & Claude A. Piantadosi. (2022) Nuclear respiratory factor-1 negatively regulates TGF-β1 and attenuates pulmonary fibrosis. iScience 25:1, pages 103535.
Crossref
Crossref
Alsya J. Affandi, Tiago Carvalheiro, Andrea Ottria, Judith J. de Haan, Maike A.D. Brans, Maarten M. Brandt, Ralph G. Tieland, Ana P. Lopes, Beatriz Malvar Fernández, Cornelis P.J. Bekker, Maarten van der Linden, Maili Zimmermann, Barbara Giovannone, Catharina G.K. Wichers, Samuel Garcia, Michael de Kok, Giuseppina Stifano, Yan Juan Xu, M. Anna Kowalska, Maaike Waasdorp, Caroline Cheng, Susan Gibbs, Saskia C.A. de Jager, Joel A.G. van Roon, Timothy R.D.J. Radstake & Wioleta Marut. (2022) CXCL4 drives fibrosis by promoting several key cellular and molecular processes. Cell Reports 38:1, pages 110189.
Crossref
Crossref
Ben A. Calvert, Zareeb Lorenzana, Christiana N. Senger, Che-Yu Hsu, Shana N. Busch, Sinem Koc-Gunel, Erik J. Quiroz & Amy L. Ryan. 2022. Novel Concepts in iPSC Disease Modeling. Novel Concepts in iPSC Disease Modeling
1
58
.
Junwen Han, Gu Li, Minmin Hou, Julie Ng, Min-Young Kwon, Kevin Xiong, Xiaoliang Liang, Elizabeth Taglauer, Yuanyuan Shi, S. Alex Mitsialis, Stella Kourembanas, Souheil El-Chemaly, James A. Lederer, Ivan O. Rosas, Mark A. Perrella & Xiaoli Liu. (2021) Intratracheal transplantation of trophoblast stem cells attenuates acute lung injury in mice. Stem Cell Research & Therapy 12:1.
Crossref
Crossref
Yunzhang Wu, Yongchao Qi, Zhibing Qiu & Wen Chen. (2021) Deficiency of CARMA3 attenuates the development of bleomycin induced pulmonary fibrosis. Biochemical and Biophysical Research Communications 581, pages 81-88.
Crossref
Crossref
Cherry Kim, Sang Hoon Jeong, Jaeyoung Kim, Ja Young Kang, Yoon Jeong Nam, Ariunaa Togloom, Jaehyung Cha, Ki Yeol Lee, Chang Hyun Lee, Eun-Kee Park & Ju-Han Lee. (2021) Evaluation of the effect of filtered ultrafine particulate matter on bleomycin-induced lung fibrosis in a rat model using computed tomography, histopathologic analysis, and RNA sequencing. Scientific Reports 11:1.
Crossref
Crossref
Bo-Min Kim, Ye-Ji Lee, Youn-Hee Choi, Eun-Mi Park & Jihee Lee Kang. (2021) Gas6 Ameliorates Inflammatory Response and Apoptosis in Bleomycin-Induced Acute Lung Injury. Biomedicines 9:11, pages 1674.
Crossref
Crossref
Long Li, Yong-Hao Lao & Nan Zhang. (2021) Time course of histopathological changes after bleomycin sclerotherapy in rabbit gallbladders as a model for simple hepatic cysts. Biomedical Reports 15:3.
Crossref
Crossref
Elizabeth F. Redente, Bart P. Black, Donald S. Backos, Ali N. Bahadur, Stephen M. Humphries, David A. Lynch, Rubin M. Tuder, Rachel L. Zemans & David W. H. Riches. (2021) Persistent, Progressive Pulmonary Fibrosis and Epithelial Remodeling in Mice. American Journal of Respiratory Cell and Molecular Biology 64:6, pages 669-676.
Crossref
Crossref
Gyu-Tae Park, Jung-Won Yoon, Sang-Bin Yoo, Young-Chul Song, Parkyong Song, Hyoung-Kyu Kim, Jin Han, Sung-Jin Bae, Ki-Tae Ha, Natalia P. Mishchenko, Sergey A. Fedoreyev, Valentin A. Stonik, Moon-Bum Kim & Jae-Ho Kim. (2021) Echinochrome A Treatment Alleviates Fibrosis and Inflammation in Bleomycin-Induced Scleroderma. Marine Drugs 19:5, pages 237.
Crossref
Crossref
Alessandro Venosa, James G. Gow, Sheryse Taylor, Thea N. Golden, Alexa Murray, Elena Abramova, Rama Malaviya, Debra L. Laskin & Andrew J. Gow. (2021) Myeloid cell dynamics in bleomycin-induced pulmonary injury in mice; effects of anti-TNFα antibody. Toxicology and Applied Pharmacology 417, pages 115470.
Crossref
Crossref
Wei Wang, Ning-yuan Chen, Dewei Ren, Jonathan Davies, Kemly Philip, Holger K. Eltzschig, Michael R. Blackburn, Bindu Akkanti, Harry Karmouty-Quintana & Tingting Weng. (2021) Enhancing Extracellular Adenosine Levels Restores Barrier Function in Acute Lung Injury Through Expression of Focal Adhesion Proteins. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Suzan M. Mansour, Hanan S. El-Abhar & Ayman A. Soubh. (2020) MiR-200a inversely correlates with Hedgehog and TGF-β canonical/non-canonical trajectories to orchestrate the anti-fibrotic effect of Tadalafil in a bleomycin-induced pulmonary fibrosis model. Inflammopharmacology 29:1, pages 167-182.
Crossref
Crossref
Shuen-Cheng Chiang, Jihye Park, Jinhyun Bae, Hyejin Joo, Donghyun Lee, Kwan-Il Kim, Seok-Jae Ko, Jae-Woo Park, Youngmin Bu & Beom-Joon Lee. (2021) Antifibrotic effects of lilii bulbus extract in a mouse model of bleomycin-induced pulmonary fibrosis. Pharmacognosy Magazine 17:76, pages 679.
Crossref
Crossref
Masato Ishikawa & Toshiyuki Yamamoto. (2020) Antifibrogenic effects of C‐C chemokine receptor type 2 antagonist in a bleomycin‐induced scleroderma model. Experimental Dermatology 30:1, pages 179-184.
Crossref
Crossref
Nitin Verma, Komal Thapa & Kamal Dua. 2021. Targeting Cellular Signalling Pathways in Lung Diseases. Targeting Cellular Signalling Pathways in Lung Diseases
903
926
.
Agnes W. Boots, Carmen Veith, Catrin Albrecht, Roger Bartholome, Marie-José Drittij, Sandra M. H. Claessen, Aalt Bast, Martin Rosenbruch, Leonie Jonkers, Frederik-Jan van Schooten & Roel P. F. Schins. (2020) The dietary antioxidant quercetin reduces hallmarks of bleomycin-induced lung fibrogenesis in mice. BMC Pulmonary Medicine 20:1.
Crossref
Crossref
Masaki Suzuki, Jun Ikari, Rie Anazawa, Nozomi Tanaka, Yusuke Katsumata, Ayako Shimada, Eiko Suzuki & Koichiro Tatsumi. (2020) PAD4 Deficiency Improves Bleomycin-induced Neutrophil Extracellular Traps and Fibrosis in Mouse Lung. American Journal of Respiratory Cell and Molecular Biology 63:6, pages 806-818.
Crossref
Crossref
Julie C Worrell, Jack Leslie, Graham R Smith, Marco Y W Zaki, Hannah L Paish, Amber Knox, Michelle L James, Tyrell N Cartwright, Steven O’Reilly, Gabriela Kania, Oliver Distler, Jörg H W Distler, Ariane L Herrick, Maria Jeziorska, Lee A Borthwick, Andrew J Fisher, Jelena Mann, Derek A Mann & Fiona Oakley. (2020) cRel expression regulates distinct transcriptional and functional profiles driving fibroblast matrix production in systemic sclerosis. Rheumatology 59:12, pages 3939-3951.
Crossref
Crossref
Rama Malaviya, Howard M. Kipen, Rita Businaro, Jeffrey D. Laskin & Debra L. Laskin. (2020) Pulmonary toxicants and fibrosis: innate and adaptive immune mechanisms. Toxicology and Applied Pharmacology 409, pages 115272.
Crossref
Crossref
Elaine Lai-Han Leung, Hu-Dan Pan, Yu-Feng Huang, Xing-Xing Fan, Wan-Ying Wang, Fang He, Jun Cai, Hua Zhou & Liang Liu. (2020) The Scientific Foundation of Chinese Herbal Medicine against COVID-19. Engineering 6:10, pages 1099-1107.
Crossref
Crossref
Nandhine Rajasekar, Ayyanar Sivanantham, Amrita Kar, Santanu Kar Mahapatra, Rajesh Ahirwar, Rajesh K. Thimmulappa, Sudhakar Gandhi Paramasivam & Rajasekaran Subbiah. (2020) Tannic acid alleviates experimental pulmonary fibrosis in mice by inhibiting inflammatory response and fibrotic process. Inflammopharmacology 28:5, pages 1301-1314.
Crossref
Crossref
Huseyin Gungor, Mehmet Ekici, Mehmet Onder Karayigit, Nergiz Hacer Turgut, Haki Kara & Emre Arslanbas. (2020) Zingerone ameliorates oxidative stress and inflammation in bleomycin-induced pulmonary fibrosis: modulation of the expression of TGF-β1 and iNOS. Naunyn-Schmiedeberg's Archives of Pharmacology 393:9, pages 1659-1670.
Crossref
Crossref
Yanan Liu, Chu Wang, Hao Chen, Maowei Zhang, Jiechen Zhu, Xiaojiao Zhang, Lei Ji, Shuyang Zhu, Wenhui Zhang & Bi Chen. (2020) The profibrotic effects of chronic microaspiration of bile acids on lungs of rats at different stages. International Immunopharmacology 84, pages 106545.
Crossref
Crossref
Mohammed O. Kseibati, George S.G. Shehatou, Maha H. Sharawy, Ahmed E. Eladl & Hatem A. Salem. (2020) Nicorandil ameliorates bleomycin-induced pulmonary fibrosis in rats through modulating eNOS, iNOS, TXNIP and HIF-1α levels. Life Sciences 246, pages 117423.
Crossref
Crossref
Pauline T. Lukey, Christopher Coello, Roger Gunn, Christine Parker, Frederick J. Wilson, Azeem Saleem, Nadia Garman, Maria Costa, Stuart Kendrick, Mayca Onega, Arthur R. Kang’ombe, Allan Listanco, James Davies, Joaquim Ramada-Magalhaes, Sara Moz, William A. Fahy, Toby M. Maher, Gisli Jenkins, Jan Passchier & Richard P. Marshall. (2019) Clinical quantification of the integrin αvβ6 by [18F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study). European Journal of Nuclear Medicine and Molecular Imaging 47:4, pages 967-979.
Crossref
Crossref
Jie Dong. (2020) Microenvironmental Alterations in Carbon Nanotube-Induced Lung Inflammation and Fibrosis. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Junmo Ahn, Hyejin Joo, Jihye Park, Jae-Woo Park, Kwan-Il Kim, Hee-Jae Jung, Youngmin Bu & Beom-Joon Lee. (2020) The Effects of Lung-Moistening Herbal Medicines on Bleomycin-Induced Pulmonary Fibrosis Mouse Model. Processes 8:1, pages 102.
Crossref
Crossref
Ana M. Diaz-Espinosa, Patrick A. Link, Delphine Sicard, Ignasi Jorba, Daniel J. Tschumperlin & Andrew J. Haak. (2020) Dopamine D1 receptor stimulates cathepsin K-dependent degradation and resorption of collagen I in lung fibroblasts. Journal of Cell Science.
Crossref
Crossref
Auriléia Aparecida de Brito, Elaine Cristina da Silveira, Nicole Cristine Rigonato-Oliveira, Stephanie Souza Soares, Maysa Alves Rodrigues Brandao-Rangel, Clariana Rodrigues Soares, Tawany Gonçalves Santos, Cintia Estefano Alves, Karine Zanella Herculano, Rodolfo Paula Vieira, Adriana Lino-dos-Santos-Franco, Regiane Albertini, Flavio Aimbire & Ana Paula de Oliveira. (2020) Low-level laser therapy attenuates lung inflammation and airway remodeling in a murine model of idiopathic pulmonary fibrosis: Relevance to cytokines secretion from lung structural cells. Journal of Photochemistry and Photobiology B: Biology 203, pages 111731.
Crossref
Crossref
Silvia Moimas, Francesco Salton, Beata Kosmider, Nadja Ring, Maria C. Volpe, Karim Bahmed, Luca Braga, Michael Rehman, Simone Vodret, Maria Laura Graziani, Marla R. Wolfson, Nathaniel Marchetti, Thomas J. Rogers, Mauro Giacca, Gerard J. Criner, Serena Zacchigna & Marco Confalonieri. (2019) miR-200 family members reduce senescence and restore idiopathic pulmonary fibrosis type II alveolar epithelial cell transdifferentiation. ERJ Open Research 5:4, pages 00138-2019.
Crossref
Crossref
Vadim Zhernovkov, Tapesh Santra, Hilary Cassidy, Oleksii Rukhlenko, David Matallanas, Aleksandar Krstic, Walter Kolch, Vladimir Lobaskin & Boris N Kholodenko. (2019) An Integrative Computational Approach for a Prioritization of Key Transcription Regulators Associated With Nanomaterial-Induced Toxicity. Toxicological Sciences 171:2, pages 303-314.
Crossref
Crossref
Yunjuan Nie, Dan Zhang, Feng Qian & Yaxian Wu. (2019) Baccatin III ameliorates bleomycin-induced pulmonary fibrosis via suppression of TGF-β1 production and TGF-β1-induced fibroblast differentiation. International Immunopharmacology 74, pages 105696.
Crossref
Crossref
Huajun Yu, Zhao Zhang, Hui Huang, Yajun Wang, Biyun Lin, Shang Wu, Jingyao Ma, Baoan Chen, Zhan He, Jun Wu, Zuguo Zhao & Haitao Zhang. (2019)
Inhibition of bleomycin-induced pulmonary fibrosis in mice by the novel peptide EZY-1 purified from
Eucheuma
. Food & Function 10:6, pages 3198-3208.
Crossref
Crossref
Rui Shao, Fu-jiang Wang, Ming Lyu, Jian Yang, Peng Zhang & Yan Zhu. (2019) Ability to Suppress TGF-β-Activated Myofibroblast Differentiation Distinguishes the Anti-pulmonary Fibrosis Efficacy of Two Danshen-Containing Chinese Herbal Medicine Prescriptions. Frontiers in Pharmacology 10.
Crossref
Crossref
Like Zhao, Bingyao Mu, Rongwei Zhou, Yongjing Cheng & Cibo Huang. (2019) Iguratimod ameliorates bleomycin‐induced alveolar inflammation and pulmonary fibrosis in mice by suppressing expression of matrix metalloproteinase‐9. International Journal of Rheumatic Diseases 22:4, pages 686-694.
Crossref
Crossref
Matea Cedilak, Mihailo Banjanac, Daniela Belamarić, Andrea Paravić Radičević, Ivan Faraho, Krunoslav Ilić, Snježana Čužić, Ines Glojnarić, Vesna Eraković Haber & Martina Bosnar. (2019) Precision-cut lung slices from bleomycin treated animals as a model for testing potential therapies for idiopathic pulmonary fibrosis. Pulmonary Pharmacology & Therapeutics 55, pages 75-83.
Crossref
Crossref
Henrik J. Jürgensen, Kirstine S. Nørregaard, Megan M. Sibree, Eric Santoni-Rugiu, Daniel H. Madsen, Katharina Wassilew, Dorrit Krustrup, Peter Garred, Thomas H. Bugge, Lars H. Engelholm & Niels Behrendt. (2019) Immune regulation by fibroblasts in tissue injury depends on uPARAP-mediated uptake of collectins. Journal of Cell Biology 218:1, pages 333-349.
Crossref
Crossref
Helen I Warheit‐Niemi, Elissa M Hult & Bethany B Moore. (2019) A pathologic two‐way street: how innate immunity impacts lung fibrosis and fibrosis impacts lung immunity. Clinical & Translational Immunology 8:6.
Crossref
Crossref
Antti Pemmari, Tiina Leppänen, Erja-Leena Paukkeri, Morena Scotece, Mari Hämäläinen & Eeva Moilanen. (2018) Attenuating Effects of Nortrachelogenin on IL-4 and IL-13 Induced Alternative Macrophage Activation and on Bleomycin-Induced Dermal Fibrosis. Journal of Agricultural and Food Chemistry 66:51, pages 13405-13413.
Crossref
Crossref
Laura A. Hancock, Corinne E. Hennessy, George M. Solomon, Evgenia Dobrinskikh, Alani Estrella, Naoko Hara, David B. Hill, William J. Kissner, Matthew R. Markovetz, Diane E. Grove Villalon, Matthew E. Voss, Guillermo J. Tearney, Kate S. Carroll, Yunlong Shi, Marvin I. Schwarz, William R. Thelin, Steven M. Rowe, Ivana V. Yang, Christopher M. Evans & David A. Schwartz. (2018) Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice. Nature Communications 9:1.
Crossref
Crossref
Li Luo, Chang-Cheng Wang, Xiao-Ping Song, Hong-Mei Wang, Hui Zhou, Ying Sun, Xiao-Kun Wang, Shuo Hou & Fu-Yang Pei. (2018) Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway. Biomedicine & Pharmacotherapy 105, pages 841-847.
Crossref
Crossref
Mahesh M. Gouda & Yashodhar P. Bhandary. (2018) Curcumin down‐regulates IL‐17A mediated p53‐fibrinolytic system in bleomycin induced acute lung injury in vivo. Journal of Cellular Biochemistry 119:9, pages 7285-7299.
Crossref
Crossref
Mahesh Manjunath Gouda, Ashwini Prabhu & Yashodhar Prabhakar Bhandary. (2018) IL-17A suppresses and curcumin up-regulates Akt expression upon bleomycin exposure. Molecular Biology Reports 45:4, pages 645-650.
Crossref
Crossref
Yangyang Gu, Bo Huang, Yanfei Yang, Mengdie Qi, Guohua Lu, Dajing Xia & Hequan Li. (2018) Ibrutinib Exacerbates Bleomycin-Induced Pulmonary Fibrosis via Promoting Inflammation. Inflammation 41:3, pages 904-913.
Crossref
Crossref
Aastha Arora, Vikas Bhuria, Puja P. Hazari, Uma Pathak, Sweta Mathur, Bal G. Roy, Rajat Sandhir, Ravi Soni, Bilikere S. Dwarakanath & Anant N. Bhatt. (2018) Amifostine Analog, DRDE-30, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice. Frontiers in Pharmacology 9.
Crossref
Crossref
Takashi Kida, Takahiro Seno, Hidetake Nagahara, Takuya Inoue, Amane Nakabayashi, Yuji Kukida, Kazuki Fujioka, Wataru Fujii, Makoto Wada, Masataka Kohno & Yutaka Kawahito. (2018) Roles of high-mobility group box 1 and thrombin in murine pulmonary fibrosis and the therapeutic potential of thrombomodulin. American Journal of Physiology-Lung Cellular and Molecular Physiology 314:3, pages L473-L483.
Crossref
Crossref
Yaser Hosny Ali Elewa, Osamu Ichii, Kensuke Takada, Teppei Nakamura, Md. Abdul Masum & Yasuhiro Kon. (2018) Histopathological Correlations between Mediastinal Fat-Associated Lymphoid Clusters and the Development of Lung Inflammation and Fibrosis following Bleomycin Administration in Mice. Frontiers in Immunology 9.
Crossref
Crossref
Katy M. Roach, Amanda Sutcliffe, Laura Matthews, Gill Elliott, Chris Newby, Yassine Amrani & Peter Bradding. (2018) A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis. Scientific Reports 8:1.
Crossref
Crossref
Cheng Chen, Yong-yan Wang, Ying-xia Wang, Meng-qun Cheng, Jian-bing Yin, Xuan Zhang & Zhi-peng Hong. (2018) Gentiopicroside ameliorates bleomycin-induced pulmonary fibrosis in mice via inhibiting inflammatory and fibrotic process. Biochemical and Biophysical Research Communications 495:4, pages 2396-2403.
Crossref
Crossref
Florian Wirsdörfer & Verena Jendrossek. (2017) Modeling DNA damage-induced pneumopathy in mice: insight from danger signaling cascades. Radiation Oncology 12:1.
Crossref
Crossref
Jie Dong & Qiang Ma. (2017) Osteopontin enhances multi-walled carbon nanotube-triggered lung fibrosis by promoting TGF-β1 activation and myofibroblast differentiation. Particle and Fibre Toxicology 14:1.
Crossref
Crossref
Koji Sakamoto, Satoru Ito, Naozumi Hashimoto & Yoshinori Hasegawa. (2017) Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma. BMC Cancer 17:1.
Crossref
Crossref
Yong Zhou, Ping Li, Jia-Xi Duan, Tian Liu, Xin-Xin Guan, Wen-Xiu Mei, Yong-Ping Liu, Guo-Ying Sun, Li Wan, Wen-Jing Zhong, Dong-Sheng Ouyang & Cha-Xiang Guan. (2017) Aucubin Alleviates Bleomycin-Induced Pulmonary Fibrosis in a Mouse Model. Inflammation 40:6, pages 2062-2073.
Crossref
Crossref
Mehrzad Bahtouee, Hossein Fatemikia, Khalil Pourkhalili, Euikyung Kim, Hamid Reza Rahimi, Zahra Tavosi, Abdol hamid Esmaili, Abdollah Hajivandi, Yaghoob Hassan & Ramin Seyedian. (2017) Saffron Protection against Bleomycin-Induced Pulmonary Fibrosis in Rats. Iranian Jornal of Toxicology 11:6, pages 7-12.
Crossref
Crossref
Fumiko Marttila‐Ichihara, Kati Elima, Kaisa Auvinen, Tibor Z. Veres, Pia Rantakari, Christopher Weston, Masayuki Miyasaka, David Adams, Sirpa Jalkanen & Marko Salmi. (2017) Amine oxidase activity regulates the development of pulmonary fibrosis. The FASEB Journal 31:6, pages 2477-2491.
Crossref
Crossref
Haiyan Chu, Ying Shi, Shuai Jiang, Qicheng Zhong, Yongqiang Zhao, Qingmei Liu, Yanyun Ma, Xiangguang Shi, Weifeng Ding, Xiaodong Zhou, Jimin Cui, Li Jin, Gang Guo & Jiucun Wang. (2017) Treatment effects of the traditional Chinese medicine Shenks in bleomycin-induced lung fibrosis through regulation of TGF-beta/Smad3 signaling and oxidative stress. Scientific Reports 7:1.
Crossref
Crossref
Xiang Zhou, Xionghua Sun & Xiaogang Jiang. (2017) Comparative proteome profiling of bleomycin-induced lung toxicity in rats by 2D-nano-LC-MS/MS and spectral counting. Biomedical Chromatography 31:4, pages e3857.
Crossref
Crossref
Chaomin Wu, Colin E. Evans, Zhiyu Dai, Xiaojia Huang, Xianming Zhang, Hua Jin, Guochang Hu, Yuanlin Song & You-Yang Zhao. (2017) Lipopolysaccharide-induced endotoxemia in corn oil-preloaded mice causes an extended course of lung injury and repair and pulmonary fibrosis: A translational mouse model of acute respiratory distress syndrome. PLOS ONE 12:3, pages e0174327.
Crossref
Crossref
Gary C. Mouradian, Rohit Gaurav, Steve Pugliese, Karim El Kasmi, Brittany Hartman, Laura Hernandez-Lagunas, Kurt R. Stenmark, Russell P. Bowler & Eva Nozik-Grayck. (2017) Superoxide Dismutase 3 R213G Single-Nucleotide Polymorphism Blocks Murine Bleomycin-Induced Fibrosis and Promotes Resolution of Inflammation. American Journal of Respiratory Cell and Molecular Biology 56:3, pages 362-371.
Crossref
Crossref
Jie Dong & Qiang Ma. (2016) Myofibroblasts and lung fibrosis induced by carbon nanotube exposure. Particle and Fibre Toxicology 13:1.
Crossref
Crossref
Matthias Ochs, Lars Knudsen, Jan Hegermann, Christoph Wrede, Roman Grothausmann & Christian M?hlfeld. (2016) Using electron microscopes to look into the lung. Histochemistry and Cell Biology 146:6, pages 695-707.
Crossref
Crossref
Luke Barron, Sina A. Gharib & Jeremy S. Duffield. (2016) Lung Pericytes and Resident Fibroblasts. The American Journal of Pathology 186:10, pages 2519-2531.
Crossref
Crossref
Swati Bhattacharyya, Wenxia Wang, Luisa Morales-Nebreda, Gang Feng, Minghua Wu, Xiaodong Zhou, Robert Lafyatis, Jungwha Lee, Monique Hinchcliff, Carol Feghali-Bostwick, Katja Lakota, G. R. Scott Budinger, Kirtee Raparia, Zenshiro Tamaki & John Varga. (2016) Tenascin-C drives persistence of organ fibrosis. Nature Communications 7:1.
Crossref
Crossref
Rudolf K. Braun, Jill M. Koch, Timothy A. Hacker, David Pegelow, Jaehyup Kim, Amish N. Raval, Eric G. Schmuck, Denise J. Schwahn, Derek J. Hei, John M. Centanni, Marlowe Eldridge & Peiman Hematti. (2016) Cardiopulmonary and histological characterization of an acute rat lung injury model demonstrating safety of mesenchymal stromal cell infusion. Cytotherapy 18:4, pages 536-545.
Crossref
Crossref
Nejat Altintas, Mustafa Erboga, Cevat Aktas, Bulent Bilir, Murat Aydin, Aysun Sengul, Zehra Ates, Birol Topcu & Ahmet Gurel. (2015) Protective Effect of Infliximab, a Tumor Necrosis Factor-Alfa Inhibitor, on Bleomycin-Induced Lung Fibrosis in Rats. Inflammation 39:1, pages 65-78.
Crossref
Crossref
Gi-Su OhSu-Bin LeeAnjani KarnaHyung-Jin KimAiHua ShenArpana PanditSeungHoon LeeSei-Hoon YangHong-Seob So. (2016)
Increased Cellular NAD
+
Level through NQO1 Enzymatic Action Has Protective Effects on Bleomycin-Induced Lung Fibrosis in Mice
. Tuberculosis and Respiratory Diseases 79:4, pages 257.
Crossref
Crossref
Michael G Crooks & Simon P Hart. (2015) Biomarkers in idiopathic pulmonary fibrosis: picking the winners for trials. The Lancet Respiratory Medicine 3:6, pages 421-422.
Crossref
Crossref
Alexandre Robbe, Alexandra Tassin, Justine Carpentier, Anne-Emilie Decl?ves, Zita L?a Mekinda Ngono, Denis Nonclercq & Alexandre Legrand. (2015) Intratracheal Bleomycin Aerosolization: The Best Route of Administration for a Scalable and Homogeneous Pulmonary Fibrosis Rat Model?. BioMed Research International 2015, pages 1-10.
Crossref
Crossref